Work

Incidence of bleeding and hypertension in patients with hematologic malignancies treated with next-generation Bruton tyrosine kinase (BTK) inhibitors: A meta-analysis of randomized controlled trials

Year: 2025

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Blood

DOI: 10.1182/blood-2025-2739

Authors: Jason Ta, Abbas Hussain, Daniel Jones, Ramaditya Srinivasmurthy, Rishi Nanda, Riccesha Hattin, Arbab Khalid, Sajal Ahmad, Sharif Afifi, Zin Win, Tin Tun, Manraj Dhillon, Kyaw Zin Thein, Thura Htut

Institutions: University of South Florida, HCA Healthcare, University of Nevada, Las Vegas, Mount Sinai Hospital, Touro University Nevada, University of California, Riverside, Comprehensive Cancer Centers of Nevada, Aberdeen Royal Infirmary

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417002083

FWCI:

Cites:

Cited by:

Related to: